NIH Clinical Research Studies

Protocol Number: 01-C-0129

Active Accrual, Protocols Recruiting New Patients

Title:
Eligibility Screening and Tissue Procurement for the National Cancer Institute (NCI) Center for Cancer Research (CCR) Clinical Protocols
Number:
01-C-0129
Summary:
The purpose of this protocol is to provide patients with adequate informed consent to understand that screening tests with minimal health risk will be performed to evaluate their eligibility for a research study. The protocol makes it clear that patients initial visit to the intramural clinical program may include screening studies that are not medically necessary for disease management, but are done purely for research purposes.

Patients with a known or suspected diagnosis of cancer, HIV infection, skin disorder or immunodeficiency who are being considered for enrollment in a National Cancer Institute intramural clinical research protocol will participate in this consent protocol. It informs patients of screening tests and procedures involving minimal risk that are done for research purposes only, including blood tests, electrocardiogram, standard X-rays (e.g., chest X-ray), bone films, computed tomography (CT), magnetic resonance imaging (MRI), and nuclear medicine studies. It explains that other eligibility screens that are more invasive and involve greater risk, such as a biopsy, will require separate consent.

Sponsoring Institute:
National Cancer Institute (NCI)
Recruitment Detail
Type: Active Accrual Of New Subjects
Gender: Male & Female
Referral Letter Required: No
Population Exclusion(s): None

Eligibility Criteria:
INCLUSION CRITERIA:

Patients who are being evaluated for and treated on protocols within the CCR.

All patients or their legal guardians (if the patient is less than 18 years of age) must sign a document of informed consent indicating their understanding of the research nature and the risks of the procedures that will be performed to assess eligibility for research protocols.

Patients or their parents/guardians can refuse to participate in the tissue procurement portion of this protocol and still participate in the screening eligibility on CCR research trials.

A Durable Power of Attorney will be offered to all patients greater than 18 years of age who are potentially cognitively impaired.

EXCLUSION CRITERIA:

None

Special Instructions: Currently Not Provided
Keywords:
Screening
Cancer
AIDS
Recruitment Keywords:
HIV
Skin Disorders
Cancer
Screening
Conditions:
Cancer
HIV Infection
Skin Disease
Investigational Drug(s):
None
Investigational Device(s):
None

Contacts:
Susan L. Bakke, R.N.
National Institutes of Health
Building 10
Room 12N226
10 Center Drive
Bethesda, Maryland 20892
Phone: (301) 435-5610
Fax: (301) 480-7281
Electronic Address: bakkes@mail.nih.gov

Citations: Not Provided

Active Accrual, Protocols Recruiting New Patients

If you have:


Command Menu Bar

Search The Studies | Help | Questions |
Clinical Center Home | NIH Home


Clinical Center LogoWarren Grant Magnuson Clinical Center (CC)
National Institutes of Health (NIH)
Bethesda, Maryland 20892. Last update: 10/16/2004

Search The Studies Help Questions